AstraZeneca Pharma India has received Import and Market permission in Form CT-20 (Marketing Authorization- Additional Indication) from the Drugs Controller General of India for Dapagliflozin film coated tablet 10mg.

Dapagliflozin film coated tablet 10mg is additional indication in adults for the treatment of heart failure with reduced ejection fraction.

The receipt of this Import and Market permission paves way for launch of Dapagliflozin film coated tablet 10mg in India, subject to the receipt of related statutory approvals and licenses.

Force Motors announced that in the month of June 2020, the company achieved production of 879 units, domestic sales of 726 units and exports of 134 units.

Century Textiles & Industries will hold a meeting of the Board of Directors of the Company on 14 July 2020.

Greaves Cotton announced that its wholly owned subsidiary, Ampere Vehicles has signed definitive agreements on 6 July, 2020 to acquire shares of Bestway Agencies on a fully diluted basis through secondary purchase. The acquisition shall be subject to completion of various closing conditions.

Bestway Agencies is in the business of development, manufacture, distribution and sale of electric vehicles, including but not limited to e-rickshaws and e-loaders.

Hindustan Construction Company will hold a meeting of the Board of Directors of the Company on 9 July 2020.

Zensar Technologies will hold a meeting of the Board of Directors of the Company on 23 July 2020.

Skyline Millars will hold a meeting of the Board of Directors of the Company on 14 July 2020.

Alembic announced that the 113th Annual General Meeting (AGM) of the company will be held on 7 August 2020.

VIP Industries will hold a meeting of the Board of Directors of the Company on 9 July 2020.

Titan Company announced that CRISIL has reaffirmed ratings in respect of the total Bank Loan facilities of Rs. 2,850 crore of the Company with a Long Term Rating CRISIL AAA/Stable & Short Term Rating CRISIL A1+.

The Company has requested CRISIL to withdrawn its rating (CRISIL A1+) on the commercial paper of Rs. 500 crore.